Identification of cancer cell fraction

AN Ayesha Noorani
XL Xiaodun Li
MG Martin Goddard
JC Jason Crawte
LA Ludmil B. Alexandrov
MS Maria Secrier
ME Matthew D. Eldridge
LB Lawrence Bower
JW Jamie Weaver
PL Pierre Lao-Sirieix
IM Inigo Martincorena
ID Irene Debiram-Beecham
NG Nicola Grehan
SM Shona MacRae
SM Shalini Malhotra
AM Ahmad Miremadi
TT Tabitha Thomas
SG Sarah Galbraith
LP Lorraine Petersen
SP Stephen D. Preston
DG David Gilligan
AH Andrew Hindmarsh
RH Richard H. Hardwick
MS Michael R. Stratton
DW David C. Wedge
RF Rebecca C. Fitzgerald
request Request a Protocol
ask Ask a question
Favorite

For each mutation we calculated the mutation copy number as previously described, using the mutant allele burden, tumor cellularity and locus specific copy number in the tumor and matched normal49. The mutation copy number reflects the percentage of tumor cells within a sample carrying that mutation, and permits the cross-comparison of the mutation in related samples despite differences in tumor purity and/ or copy number profiles. Mutations present on multiple copies of a chromosomal segment will have a mutation copy number greater than 1. To group mutations according to the percentage of cells containing it, or cancer cell fraction (CCF), the number of chromosomes carrying the mutation must be determined. For all mutations within amplified regions with a major allele copy number, the observed fraction of mutated reads was compared to the expected fraction of mutated reads resulting from a mutation present assuming a binomial distribution37.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A